Targeted nano delivery of p53 DNA and carvedilol for the treatment of dilated cardiomyopathy in a rat model

LANPs offer a promising, biocompatible platform for targeted myocardial delivery of gene and drug therapies and may serve as an effective strategy for treating cardiomyopathy.

Authors

Institutions

Publication Details

Journal
Nanomedicine
Published
2026-02-25
DOI
https://doi.org/10.1080/17435889.2026.2634274
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeted nano delivery of p53 DNA and carvedilol for the treatment of dilated cardiomyopathy in a rat model

Satyajit Mukhopadhyay, Anand K. Kondapi, Neha R. Tomar, Aruna Tara Vennela
Nanomedicine
RNA Interference and Gene Delivery
article

Targeted nano delivery of p53 DNA and carvedilol for the treatment of dilated cardiomyopathy in a rat model

Satyajit Mukhopadhyay, Anand K. Kondapi, Neha R. Tomar, Aruna Tara Vennela
article en

Abstract

LANPs offer a promising, biocompatible platform for targeted myocardial delivery of gene and drug therapies and may serve as an effective strategy for treating cardiomyopathy.

Nanomedicine
University of Hyderabad (IN)
Good health and well-being
Openalex Percentile: Top 43%
RNA Interference and Gene Delivery
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.